Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 7:08 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2209–2232 of 2,478 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Tissue Control Group Clear all

Conditions: Healthy
Interventions: Increased Dairy Consumption; Other
Lead sponsor: Purdue University; Other
Eligibility: 9 Years to 14 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 2
States / cities: Indianapolis, Indiana • West Lafayette, Indiana

Conditions: Clinical Efficacy
Interventions: One layer allograft, Two layer allograft; Procedure
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Gastroesophageal Reflux Disease (GERD)
Interventions: NDO Full-thickness Plicator, Sham Control; Device
Lead sponsor: NDO Surgical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 13
States / cities: Orange, California • San Ramon, California • Denver, Colorado + 8 more

Conditions: Pain, Postoperative
Interventions: Combined Bupivacaine and Exparel, Normal Saline (NS); Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older · Female only
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Patellofemoral Pain Syndrome
Interventions: Experimental; Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years to 44 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Weight Loss, Diet Habit, Physical Activity, Overweight and Obesity
Interventions: Koa Family; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 47 Years · Female only
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Obesity, Adolescent
Interventions: Breakfast; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 13 Years to 21 Years
Enrollment: 103 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Left Ventricular Ejection Fraction, Heart Failure (HF), Left Bundle-Branch Block
Interventions: LB-CRT, BIV-CRT; Device
Lead sponsor: Inova Health Care Services; Other
Eligibility: Not listed
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Durham, North Carolina • Falls Church, Virginia

Conditions: Plantar Fascitis
Interventions: Instrumental-assisted soft tissue mobilization (IASTM), High-Load Strength Training, Plantar Flexor and Gastrocnemius Stretching; Other
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 83 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Anxiety Disorder of Childhood
Interventions: Child Anxiety Learning Modules (CALM), Child Anxiety Learning Modules--Relaxation (CALM-R); Behavioral
Lead sponsor: UConn Health; Other
Eligibility: 5 Years to 12 Years
Enrollment: 218 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 2
States / cities: West Hartford, Connecticut • Columbia, Maryland

Conditions: Healthy Volunteers
Interventions: Shock Device, Auditory Startle Device; Device
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 1,418 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Advanced Solid Tumors
Interventions: Talazoparib; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 7
States / cities: Fort Wayne, Indiana • Detroit, Michigan • Farmington Hills, Michigan + 2 more

Conditions: Calcinosis Cutis
Interventions: Sodium Thiosulfate, Saline Solution; Drug · Other
Lead sponsor: University of Central Florida; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Congenital Hyperinsulinism
Interventions: Exendin-(9-39), Vehicle; Drug · Other
Lead sponsor: Diva De Leon; Other
Eligibility: 7 Years to 60 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: ICU Acquired Weakness, Post Intensive Care Unit Syndrome, Muscle Weakness, Critical Illness
Interventions: Not listed
Lead sponsor: Esther Dupont-Versteegden; Other
Eligibility: 18 Years and older · Male only
Enrollment: 209 participants
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: Birmingham, Alabama • Lexington, Kentucky • Oklahoma City, Oklahoma

Conditions: Moderate Traumatic Brain Injury (TBI), Severe Traumatic Brain Injury
Interventions: Valproic Acid (VPA), Standard of care treatment + normal saline; Drug · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 432 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 9
States / cities: Birmingham, Alabama • Tucson, Arizona • Los Angeles, California + 6 more

Conditions: COPD, Acute Respiratory Failure
Interventions: Revefenacin Inhalation Solution [Yupelri], Ipratropium Bromide; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 40 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 2
States / cities: Los Angeles, California • Santa Monica, California

Conditions: Anxiety Disorders, Major Depressive Disorder
Interventions: Attention Bias Modification Training, Fluoxetine, Cognitive Behavioral Therapy; Behavioral · Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 8 Years to 65 Years
Enrollment: 3,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2029
U.S. locations: 2
States / cities: Bethesda, Maryland • College Park, Maryland

Conditions: Cytokine Storm, COVID-19
Interventions: Anakinra, Normal saline; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 80 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Tinnitus
Interventions: incobotulinum toxin A, Placebo-Saline; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Tibial Fracture, Soft Tissue Injury
Interventions: Hyperbaric Oxygen Treatment; Other
Lead sponsor: Bayside Health; Government
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2016
U.S. locations: 1
States / cities: Concord, California

Conditions: Dehiscence, Tooth Extraction, Alveolar Bone Loss
Interventions: Minimally Invasive tooth extraction, Alveolar ridge preservation with ABCC, Resorbable collagen membrane (InterCollagen® Guide); Procedure · Device
Lead sponsor: Debora Dias; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: COVID-19
Interventions: BI 767551 intravenous, BI 767551 inhaled, Placebo intravenous, Placebo inhaled; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 4
States / cities: Miami Springs, Florida • Amarillo, Texas • Houston, Texas + 1 more

Conditions: Cirrhosis, Liver, End Stage Liver DIsease, Acute Kidney Injury, Liver Transplant; Complications
Interventions: Angiotensin II, Norepinephrine; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

The Effect of Dairy on Bone Mass and Body Composition in 4th-8th Grade Boys and Girls

Implant Placement and Simultaneous Soft Tissue Grafting With Single or Double Layers of Acellular Dermal Matrix

A Study to Determine the Effectiveness of Endoscopic Full-Thickness Plication for the Treatment of GERD

Long-acting Local Vaginal Cuff Anesthesia Following Hysterectomy

Running Study for Runners With Chronic Knee Pain

Koa Family: California's Obesity Prevention Project

Increased Protein at Breakfast for Weight Management in Overweight Adolescents

REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)

Effects of Exercise Versus Exercise and Instrument-Assisted Soft Tissue Mobilization for Plantar Fasciopathy Treatment

Efficacy Trial of the CALM Intervention

Effects of Arousal and Stress in Anxiety

An Open-Label Pharmacokinetics and Safety Study of Talazoparib

Efficacy of Intralesional Sodium Thiosulfate Versus Intralesional Saline for Dystrophic and Idiopathic Calcinosis Cutis

Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism

Muscle Recovery After Critical Illness

Valproic AcId for Traumatic BRAin INjury Trial

Revefenacin in Acute Respiratory Insufficiency in COPD

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Early Treatment of Cytokine Storm Syndrome in Covid-19

The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial

Hyperbaric Oxygen in Lower Leg Trauma

Effect of Collagen Membrane on Ridge Preservation

A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19

Angiotensin 2 for AKI After OLT